BioMarin Pharmaceutical Inc.

NasdaqGS-BMRN

Operating Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Net Income	426.2	231	195.8	60.8	106.9	-6.9
Net Income
Depreciation & Amortization	40.6	42.6	53.8	52.5	51.8	49.4
Depreciation and Amortization
Share-Based Compensation Expense	85.2	95.4	106.2	103.2	103.9	101.4
Stock-Based Compensation
Other Adjustments	56.1	82.2	-17.8	3.8	12.9	-57.1
Non-Cash Interest Expense
Amortization of Premium (Accretion of Discount) on Investments
Gain on Sale of Nonfinancial Assets
Gain on the Sale of Equity Investments
Gain on Sale of Equity Investment
Inventory Reserves, Net of Stock-Based Compensation
Impairment of Assets
Deferred Income Taxes
Excess Tax Benefit from Stock Option Exercises
Unrealized Foreign Exchange Loss
Non-Cash Changes in the Fair Value of Contingent Consideration
Unrealized Foreign Exchange Gain
Other
Changes in Trade Receivables	-156.1	-1.8	-56.1	-44.6	-145.8	10.5
Accounts Receivable, Net
Changes in Inventories	-72.5	-16.1	-47.4	-100.6	-56.5	-66.8
Inventory
Changes in Accounts Payable	3.1	22	-54.3	93.9	-25.1	135.4
Accounts Payable and Accrued Liabilities
Changes in Other Operating Activities	-23.1	-48.2	-14.6	-6	-51.9	-0.7
Other Current Assets
Other Assets
Other Long-Term Liabilities
Cash from Operating Activities	359.7	407.1	165.7	163.1	-3.9	165.1
Net Cash Provided by Operating Activities

Investing Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Capital Expenditure	-33.9	-38	-47.4	-50.7	-46	-65
Purchases of Property, Plant and Equipment
Proceeds from Sale of Property, Plant & Equipment	—	—	10	—	—	-6.7
Proceeds from Sale of Nonfinancial Assets
Purchases of Intangible Assets	-0.3	-3.5	-8.5	-9.5	-1.5	-7.8
Purchase of Intangible Assets
Proceeds from Sale of Intangible Assets	—	—	—	—	—	—
Proceeds from Sale of Intangible Asset
Purchases of Investments	-202.4	-214.8	-195.5	-424.4	-444	-307
Purchases of Investments
Investment in Convertible Note
Proceeds from Sale of Investments	195.7	315.4	317.6	373.8	491.1	308.4
Maturities and Sales of Investments
Payments for Business Acquisitions	—	—	—	—	—	—
Business Acquisitions, Net of Cash Acquired
Other Investing Activities	—	1.1	—	—	—	—
Other
Cash from Investing Activities	-40.8	60.2	76.2	-110.8	-0.5	-78.1
Net Cash Provided by Investing Activities

Financing Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Issuance of Long-Term Debt	—	—	—	—	—	—
Proceeds from Convertible Senior Subordinated Note Offering, Net
Repayments of Long-Term Debt	—	-495	—	1.6	-1.6	1.1
Repayments of Convertible Debt
Principal Repayments of Financing Leases
Net Issuance / (Repayments) of Long-Term Debt	—	-495	—	1.6	-1.6	1.1
Issuance of Common Shares	7.7	12.7	36.6	19.2	50.2	39.8
Proceeds from Exercises of Awards Under Equity Incentive Plans
Proceeds from Public Offering of Common Stock, Net
Repurchases of Common Shares	-51.1	-10.8	-66.7	-8.5	-67.9	-9.9
Taxes Paid Related to Net Share Settlement of Equity Awards
Repurchase of Common Stock
Net Issuance / (Repurchases) of Common Shares	-43.4	1.8	-30.1	10.7	-17.7	29.9
Other Financing Activities	—	-3.1	-0.1	-2.3	-9.5	-12.6
Excess Tax Benefit from Stock Option Exercises
Payments of Contingent Consideration
Other
Cash from Financing Activities	-43.4	-496.3	-30.2	10.1	-28.8	18.4
Net Cash Provided by (Used In) Financing Activities
Net Cash Provided by Financing Activities